DSP 0038
Alternative Names: DSP-0038Latest Information Update: 29 Nov 2024
Price :
$50 *
At a glance
- Originator Exscientia; Sunovion Pharmaceuticals
- Developer Recursion Pharmaceuticals
- Class Antipsychotics; Small molecules
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 5-HT2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Psychotic disorders